BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 2326543)

  • 1. The Protective Effect of Naringenin-Oxime on Cisplatin-Induced Toxicity in Rats.
    Koyuncu I; Kocyigit A; Gonel A; Arslan E; Durgun M
    Biochem Res Int; 2017; 2017():9478958. PubMed ID: 28932603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition.
    Brahmi D; Ayed Y; Hfaiedh M; Bouaziz C; Mansour HB; Zourgui L; Bacha H
    BMC Complement Altern Med; 2012 Jul; 12():111. PubMed ID: 22849573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.
    Hartmann JT; Fels LM; Knop S; Stolt H; Kanz L; Bokemeyer C
    Invest New Drugs; 2000 Aug; 18(3):281-9. PubMed ID: 10958599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.
    Bokemeyer C; Fels LM; Dunn T; Voigt W; Gaedeke J; Schmoll HJ; Stolte H; Lentzen H
    Br J Cancer; 1996 Dec; 74(12):2036-41. PubMed ID: 8980410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Tanino H; Watanabe M; Ishibiki K; Kitajima M
    Jpn J Cancer Res; 1993 Jul; 84(7):787-93. PubMed ID: 8370654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
    Treskes M; van der Vijgh WJ
    Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buthionine sulfoximine, an experimental tool to induce glutathione deficiency: elucidation of glutathione and ascorbate in their role as antioxidants.
    Broquist HP
    Nutr Rev; 1992 Apr; 50(4 ( Pt 1)):110-1. PubMed ID: 1614638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione and cadmium toxicity.
    Nutr Rev; 1988 Aug; 46(8):297-9. PubMed ID: 3064014
    [No Abstract]   [Full Text] [Related]  

  • 9. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of buthionine sulfoximine on the lethality of ifosfamide and ifosfamide-induced urotoxicity in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):455-8. PubMed ID: 2727395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
    Appenroth D; Winnefeld K
    Ren Fail; 1993; 15(2):135-9. PubMed ID: 8469780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
    Mizutani T; Yoshida K; Ito K
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of buthionine sulfoximine on the nephrotoxicity of 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
    Kramer RA; Schuller HM; Smith AC; Boyd MR
    J Pharmacol Exp Ther; 1985 Aug; 234(2):498-506. PubMed ID: 4020683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
    Ishikawa M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.